Evidence map›Paper›PMID 31293963›Full record

ArticleFrontiers in oncology2019

A Pre-operative Nomogram for Prediction of Lymph Node Metastasis in Bladder Urothelial Carcinoma.

Xiaofan Lu, Yang Wang, Liyun Jiang, Jun Gao, Yue Zhu, Wenjun Hu, Jiashuo Wang, Xinjia Ruan, Zhengbao Xu, Xiaowei Meng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xiaofan LuResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Yang WangDepartment of Radiology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Liyun JiangResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Jun GaoResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Yue ZhuResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Wenjun HuResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Jiashuo WangResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Xinjia RuanResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Zhengbao XuResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Xiaowei MengResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Bing ZhangDepartment of Radiology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Fangrong YanResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
China Pharmaceutical University · CNNanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The status of lymph node (LN) metastases plays a decisive role in the selection of surgical procedures and post-operative treatment. Several histopathologic features, known as predictors of LN metastasis, are commonly available post-operatively. Medical imaging improved pre-operative diagnosis, but the results are not fully satisfactory due to substantial false positives. Thus, a reliable and robust method for pre-operative assessment of LN status is urgently required. We developed a prediction model in a training set from the TCGA-BLCA cohort including 196 bladder urothelial carcinoma samples with confirmed LN metastasis status. Least absolute shrinkage and selection operator (LASSO) regression was harnessed for dimension reduction, feature selection, and LNM signature building. Multivariable logistic regression was used to develop the prognostic model, incorporating the LNM signature, and a genomic mutation of

Indexed as

bladder cancerLNM signaturelymph node metastasisMLL2 mutationpre-operative nomogram

Identifiers

PMID31293963
PMCPMC6598397
OpenAlexW2949443855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.